HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tomita, Y. Articles by Nomoto, K. Search for Related Content PubMed PubMed Citation Articles by Tomita, Y. Articles by Nomoto, K.

Induction of Permanent Mixed Chimerism and Skin Allograft Tolerance Across Fully MHC-Mismatched Barriers by the Additional Myelosuppressive Treatments in Mice Primed with Allogeneic Spleen Cells Followed by Cyclophosphamide¹

Yukihiro Tomita^2,*, Masahiro Yoshikawa, Qi-Wei Zhang^*, Ichiro Shimizu^*, Shinji Okano, Toshiro Iwai^*, Hisataka Yasui^* and Kikuo Nomoto

^* Department of Cardiovascular Surgery, Faculty of Medicine, and Department of Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan

A pure method of drug (cyclophosphamide plus busulfan)-induced skin allograft tolerance in mice that can regularly overcome fully H-2-mismatched barriers in mice has been established. The components of the method are i.v. administration of 1 x 10⁸ allogeneic spleen cells on day 0, i.p. injection of 200 mg/kg CP and 25 mg/kg busulfan on day 2, and i.v. injection of T cell-depleted 1 x 10⁷ bone marrow cells from the same donor on day 3. Recipient B10 (H-2^b; IE^-) mice prepared with this conditioning developed donor-specific tolerance, and long-lasting survival of skin allografts was shown in almost of the recipient mice. In the tolerant B10 mice prepared with new conditioning, stable multilineage mixed chimerism was observed permanently, and IE-reactive Vß11⁺ T cells were reduced in periphery as seen in untreated B10.D2 (H-2^d; IE⁺) mice. The specific tolerant state was confirmed by the specific abrogation against donor Ag in the assays of CTL activity and MLR and donor-specific acceptance in the second skin grafting. These results demonstrated that the limitation of standard protocol of cyclophosphamide-induced tolerance, which have been reported by us since 1984, can be overcome by the additional treatments with the myelosuppressive drug busulfan, followed by 1 x 10⁷ T cell-depleted bone marrow cells. To our knowledge, this is the first report to induce allograft tolerance with a short course of the Ag plus immunosuppressive drug treatment without any kind of mAbs (pure drug-induced tolerance).

This article has been cited by other articles:

				T. Iwai, Y. Tomita, S. Okano, I. Shimizu, Y. Yasunami, T. Kajiwara, Y. Yoshikai, M. Taniguchi, K. Nomoto, and H. Yasui Regulatory Roles of NKT Cells in the Induction and Maintenance of Cyclophosphamide-Induced Tolerance J. Immunol., December 15, 2006; 177(12): 8400 - 8409. [Abstract] [Full Text] [PDF]

				S. Bhattacharyya, A. Chawla, K. Smith, Y. Zhou, S. Talib, B. Wardwell, and M. J. Cowan Multilineage Engraftment with Minimal Graft-Versus-Host Disease Following In Utero Transplantation of S-59 Psoralen/Ultraviolet A Light-Treated, Sensitized T Cells and Adult T Cell-Depleted Bone Marrow in Fetal Mice J. Immunol., December 1, 2002; 169(11): 6133 - 6140. [Abstract] [Full Text] [PDF]

				M. Eto, H. Hackstein, K. Kaneko, K. Nomoto, and A. W. Thomson Promotion of Skin Graft Tolerance Across MHC Barriers by Mobilization of Dendritic Cells in Donor Hemopoietic Cell Infusions J. Immunol., September 1, 2002; 169(5): 2390 - 2396. [Abstract] [Full Text] [PDF]

				L. Luznik, S. Jalla, L. W. Engstrom, R. Iannone, and E. J. Fuchs Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide Blood, December 1, 2001; 98(12): 3456 - 3464. [Abstract] [Full Text] [PDF]